Trinseo Plc engages in the manufacture and sale of plastics and latex binders. It operates through the following segments: Engineered Materials, Latex Binders, Base Plastics, Polystyrene, Feedstocks, and Americas Styrenics. The Engineered Materials segment produces rigid thermoplastic compounds and blends products, soft thermoplastic products, and cast and sheet products. The Latex Binders segment creates styrene-butadiene latex. The Base Plastics segment manufactures a variety of compounds and blends, the majority of which are for automotive applications. The Polystyrene segment offers a variety of general-purpose polystyrenes and high impact polystyrenes. The Feedstocks segment deals with the production of styrene monomers in order to provide secure sourcing of this key raw material to the company's other segments. The Americas Styrenics segment is composed of the operations of the company's owned joint venture with Chevron Phillips Chemical Company. The company was founded on October 8, 2021 and is headquartered in Wayne, PA.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Augmedix, Inc. engages in the development of software that converts natural clinician-patient conversations into medical documentation. It offers live support including referrals, orders, and reminders that allow clinicians to focus on patient care. The company was founded by Ian Shakil in 2012 and is headquartered in San Francisco, CA.

Aurora Innovation, Inc. engages in the design and development of automobile hardware, software, and provision of data services. It primarily offers Aurora Driver which allows a vehicle to drive itself. The company was founded by Chris Urmson, Sterling Anderson and Drew Bagnell in 2017 and is headquartered in Pittsburgh, PA.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Steakholder Foods Ltd. is an international deep-tech food company, which engages in the provision of production technology and associated supplies needed to commercially produce structured alternative protein products. The firm is also involved in developing and selling two types of 3D-printing production machines and developing plant-based products that aim to replicate the complex textures of traditional meats such as beef steaks, white fish, shrimp, and eel. The company was founded by Arik Kaufman, Yaron Kaiser, Sharon Fima, and Omri Schanin on July 22, 1992 and is headquartered in Rehovot, Israel.

AnaptysBio, Inc. is a clinical stage biotechnology company. engages in the development of antibody product candidates. Its products pipeline include ANB030, ANB030, and Imsidolimab. It also offers SHM platform that replicate the natural process of somatic hypermutation embedded within the human immune system to rapidly develop a diverse range of therapeutic-grade antibodies in vitro. The company was founded by Andrew B. Cubitt, William J. Boyle, Kevin J. Kinsella, and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.

NANO Nuclear Energy Inc. operates as a microreactor technology company. The company is developing ZEUS, a solid-core battery reactor, and ODIN, a low-pressure coolant reactor. It is also developing a high-assay low-enriched uranium fabrication facility to supply fuel to the nuclear reactor industry and fuel transportation and nuclear consultation businesses. The company was founded in 2021 and is based in New York, New York.

DNOW, Inc. is a holding company, which engages in the distribution of energy products for industrial applications. It operates through the following segments: United States, Canada, and International. The United States segment serves the upstream, midstream and downstream energy, and industrial markets. The Canada segment covers energy exploration, production, drilling, and midstream business. The International segment represents the energy exploration, production, and drilling business. The company was founded on November 22, 2013 and is headquartered in Houston, TX.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.